Influence of methylated p15INK4b and p16INK4a genes on clinicopathological features in colorectal cancer

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 8, 2006, Pages 1334-1339

  Ishiguro, Atsushi ^a   Takahata, Takenori ^a   Saito, Masato ^a   Yoshiya, Gen ^a   Tamura, Yoshihiro ^a   Sasaki, Mutsuo ^a   Munakata, Akihiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Methylation; Prognosis

Indexed keywords

BISULFITE; CYCLIN DEPENDENT KINASE INHIBITOR 2B; PROTEIN P15; PROTEIN P16INK4A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CALCULATION; CANCER DIAGNOSIS; CANCER SURGERY; CANCER TISSUE; CLINICAL FEATURE; COLON MUCOSA; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METHYLATION; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL;

EID: 33745824650     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04137.x     Document Type: Article

References (27)

1. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988; 319: 525-32.
2. Neibergs HL, Hein DW, Spratt JS. Genetic profiling of colon cancer. J. Surg. Oncol. 2002; 80: 204-13.
3. Minamoto T, Sawaguchi K, Mai M, Yamashita N, Sugimura T, Esumi H. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. Cancer Res. 1994; 54: 2841-4.
4. Redston MS, Papadopoulos N, Caldas C, Kinzler KW, Kern SE. Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterology 1995; 108: 383-92.
5. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001; 61: 3573-7.
6. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 2003; 349: 2042-54.
7. Kondo Y, Issa JP. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev. 2004; 23: 29-39.
8. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB, Methylation-specific PCR. A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 1996; 93: 9821-6.
9. INK4B1. Cancer Res. 1996; 56: 722-7.
10. Jeffrey PD, Tong L, Pavletich NP. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Genes Dev. 2000; 14: 3115-25.
11. Obaya AJ, Sedivy JM. Regulation of cyclin-Cdk activity in mammalian cells. Cell Mol. Life Sci. 2002; 59: 126-42.
12. ARF locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors. Carcinogenesis 2000; 21: 2057-64.
13. INK4B is apotential effector of TGF-β-induced cell cycle arrest. Nature 1994; 371: 257-61.
14. INK4b expression and correlates with poor prognosis. Leukemia 2003; 17: 919-24.
15. Chim CS, Tam CY, Liang R, Kwong YL. Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance. Cancer 2001; 91: 2222-9.
16. Baur AS, Shaw P, Burri N, Delacrétaz F, Bosman FT, Chaubert P. Frequent methylation silencing of p15INK4b (MTS2) and p16INK4a (MTS1) in B-cell and T-cell lymphomas. Blood 1999; 94: 1773-81.
17. Hibi K, Nakayama H, Koike M et al. Colorectal cancers with both p16 and p14 methylation show invasive characteristics. Jpn. J. Cancer Res. 2002; 93: 883-7.
18. INK4a methylation and p53 mutational status. Cancer Res. 2000; 60: 129-33.
19. INK4a genes in colon cancer. Lab. Invest. 2001; 81: 217-29.
20. Shannon BA, Iacopetta BJ. Methylation of the hMLH1, 16, and Mdr1 genes in colorectal carcinoma: associations with clinicopathological features. Cancer Lett. 2001; 167: 91-7.
21. INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer. Cancer Epidem. Biomar. 1999; 8: 501-6.
22. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 1998; 58: 5489-94.
23. Gonzalez-Zulueta M, Bender CM, Yang AS et al. Methylation of the 5′-CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 1995; 55: 4531-5.
24. Chan AO, Issa JP, Morris JS, Hamilton SR, Rashid A. Concordant CpG island methylation in hyperplastic polyposis. Am. J. Pathol. 2002; 160: 529-36.
25. Liang JT, Chang KJ, Chen JC et al. Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: association with DNA replication error and shorter survival. Oncology 1999; 57: 149-56.
26. Maeda K, Kawakami K, Ishida Y, Ishiguro K, Omura K, Watanabe G. Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival. Oncol. Rep. 2003; 10: 935-8.
27. Esteller M, González S, Risques RA et al. K-ras and p16 aberrations confer poor prognosis in human colorectal cancer. J. Clin. Oncol. 2001; 19: 299-304.